3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
42
Lymphoma, Large B-Cell, Diffuse
34
Burkitt Lymphoma
32
Lymphoma
25
Lymphoma, Follicular
17
Rhabdomyosarcoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, B-Cell
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
10
Leukemia
10
Sarcoma, Ewing
9
Medulloblastoma
9
Leukemia, Biphenotypic, Acute
9
Recurrence
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Wilms Tumor
5
Sarcoma
5
Retinoblastoma
5
Osteosarcoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Ganglioneuroblastoma
4
Down Syndrome
4
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Vincristine
×
1 year
×
Clear all
NCT05384821
2026-03-18
MetroWilms
Centre Oscar Lambret
Phase 1/2
Recruiting
28 enrolled